These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 23345409)

  • 1. Pharmacogenomics in the pocket of every patient? A prototype based on quick response codes.
    Samwald M; Adlassnig KP
    J Am Med Inform Assoc; 2013 May; 20(3):409-12. PubMed ID: 23345409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ontology-based, mobile-optimized system for pharmacogenomic decision support at the point-of-care.
    Miñarro-Giménez JA; Blagec K; Boyce RD; Adlassnig KP; Samwald M
    PLoS One; 2014; 9(5):e93769. PubMed ID: 24787444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
    Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
    Stud Health Technol Inform; 2014; 198():25-31. PubMed ID: 24825681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards a global IT system for personalized medicine: the Medicine Safety Code initiative.
    Samwald M; Minarro-Giménez JA; Blagec K; Adlassnig KP
    Stud Health Technol Inform; 2014; 205():261-5. PubMed ID: 25160186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining perceptions of the usefulness and usability of a mobile-based system for pharmacogenomics clinical decision support: a mixed methods study.
    Blagec K; Romagnoli KM; Boyce RD; Samwald M
    PeerJ; 2016; 4():e1671. PubMed ID: 26925317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomic knowledge representation, reasoning and genome-based clinical decision support based on OWL 2 DL ontologies.
    Samwald M; Miñarro Giménez JA; Boyce RD; Freimuth RR; Adlassnig KP; Dumontier M
    BMC Med Inform Decis Mak; 2015 Feb; 15():12. PubMed ID: 25880555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacogenomic Primer for the Pediatrician-What Is Really Important?
    Manzi S
    Pediatr Ann; 2018 May; 47(5):e217-e219. PubMed ID: 29750289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrating pharmacogenomics into electronic health records with clinical decision support.
    Hicks JK; Dunnenberger HM; Gumpper KF; Haidar CE; Hoffman JM
    Am J Health Syst Pharm; 2016 Dec; 73(23):1967-1976. PubMed ID: 27864204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physician perspectives of CYP2C19 and clopidogrel drug-gene interaction active clinical decision support alerts.
    Nishimura AA; Shirts BH; Salama J; Smith JW; Devine B; Tarczy-Hornoch P
    Int J Med Inform; 2016 Feb; 86():117-25. PubMed ID: 26642939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pharmacogenomics - a cornerstone of Precision Medicine. Genomic Medicine Sweden analyses genotypes associated with serious drug toxicity or therapeutic failure].
    Eliasson E; Wadelius M
    Lakartidningen; 2021 May; 118():. PubMed ID: 33973222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenges of implementing pharmacogenomic testing in the clinic.
    Moyer AM; Caraballo PJ
    Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):567-577. PubMed ID: 28949250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenomics in dermatology: tools for understanding gene-drug associations.
    Daneshjou R; Huddart R; Klein TE; Altman RB
    Semin Cutan Med Surg; 2019 Mar; 38(1):E19-E24. PubMed ID: 31051019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
    Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
    Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are we PREPAREd? Concerning the "PREemptive Pharmacogenomics Testing for Preventing Adverse Drug Reactions (PREPARE) Study".
    De Carmo Campos A; Cardoso ML; Vicente A
    Acta Med Port; 2023 Oct; 36(10):689-690. PubMed ID: 37788651
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress of pharmacogenomic research related to minerals and trace elements.
    Zeng MZ; Tang J; Liu ZQ; Zhou HH; Zhang W
    Pharmazie; 2015 Oct; 70(10):629-35. PubMed ID: 26601417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving Pain Management with Pharmacogenomics: A General Introduction.
    Schuh MJ; Randles H; Crosby S
    J Pain Palliat Care Pharmacother; 2020 Sep; 34(3):114-119. PubMed ID: 32186418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of pharmacogenomics in elderly patients treated for cardiovascular diseases.
    Božina N; Vrkić Kirhmajer M; Šimičević L; Ganoci L; Mirošević Skvrce N; Klarica Domjanović I; Merćep I
    Croat Med J; 2020 Apr; 61(2):147-158. PubMed ID: 32378381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotype-guided warfarin therapy: current status.
    Tavares LC; Marcatto LR; Santos PCJL
    Pharmacogenomics; 2018 May; 19(7):667-685. PubMed ID: 29701078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards Pharmacogenomics-Driven Medication Risk Assessment in People with Polypharmacy.
    Liu J; Finkelstein J
    Stud Health Technol Inform; 2018; 247():880-884. PubMed ID: 29678087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.